Aytu Biopharma (AYTU) Share-based Compensation (2014 - 2026)
Aytu Biopharma (AYTU) recorded Share-based Compensation of $146,000 in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 29.2% from $113,000 a year earlier but down 1.4% from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Share-based Compensation (2014 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Aytu Biopharma reported Share-based Compensation of $691,000, up 20.0% from FY2025.
- Annual Share-based Compensation has a five-year compound annual growth rate of -28.0% (FY2021 to FY2026).
- Across earlier fiscal years, Share-based Compensation came in at $576,000 in FY2025 (-75.7%), $2.37 million in FY2024 (-60.8%), $6.05 million in FY2023 (+15.2%) and $5.25 million in FY2022 (+46.8%).
- Quarterly Share-based Compensation has ranged from $113,000 in fiscal Q4 2025 to $3.07 million in fiscal Q2 2023 over the past five years.
- On a year-over-year basis, Share-based Compensation has increased for three consecutive quarters, with an average decline of 26.3% over the last eight quarters.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 233.8% in fiscal Q1 2022, against a decline of 82.9% in fiscal Q3 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $148,000 (Q3 2026), $283,000 (Q2 2026) and $114,000 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Aytu Biopharma | 23.58 Mn | -92.10 Mn | 10.41 Mn | 146,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 146,000.00 |
| Mar 31, 2026 | 148,000.00 |
| Dec 31, 2025 | 283,000.00 |
| Sep 30, 2025 | 114,000.00 |
| Jun 30, 2025 | 113,000.00 |
| Mar 31, 2025 | 139,000.00 |
| Dec 31, 2024 | 151,000.00 |
| Sep 30, 2024 | 173,000.00 |
| Jun 30, 2024 | 242,000.00 |
| Mar 31, 2024 | 811,000.00 |
| Dec 31, 2023 | 820,000.00 |
| Sep 30, 2023 | 930,000.00 |
| Jun 30, 2023 | 900,000.00 |
| Mar 31, 2023 | 902,000.00 |
| Dec 31, 2022 | 3.07 Mn |
| Sep 30, 2022 | 1.18 Mn |
| Jun 30, 2022 | 1.23 Mn |
| Mar 31, 2022 | 1.27 Mn |
| Dec 31, 2021 | 1.23 Mn |
| Sep 30, 2021 | 1.52 Mn |
API Access
Aytu Biopharma Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();